Potassium Chloride Injection Strength Mislabeled on Packaging Overwrap
ICU Medical recalls Potassium Chloride Injection (lot 1023172) whose overwrap labeled as 10 mEq may contain 20 mEq containers, creating overdose risk. Product distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA classified this as Class I, which requires a minimum severity score of 4 per the rubric. The mislabeling of potassium chloride strength (10 mEq labeled but 20 mEq contained) creates serious risk of medication error and patient harm, despite no illnesses currently reported.
Plain-English summary
ICU Medical, Inc. is recalling Potassium Chloride Injection, NDC 0990-7074-26, a prescription intravenous medication. The product's overwrap is labeled as Potassium Chloride Injection 10 mEq in 100 mL flexible container, but some containers in affected lot 1023172 contain 20 mEq instead.
This labeling discrepancy creates a serious risk of medication error. Healthcare workers or patients may administer the incorrect strength based on the label, potentially resulting in a dose double what was intended. Potassium chloride is a critical electrolyte supplement, and dosing errors can lead to serious patient harm.
The affected product, lot 1023172 with expiration date January 31, 2026, has been distributed nationwide throughout the United States.
The recalled product
- Product
- POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
- Brand
- POTASSIUM CHLORIDE
- Manufacturer
- ICU Medical, Inc.
- Category
- Drug — Intravenous Electrolyte
- Hazard
- mis-labeling
- dosage-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 1023172
- Exp Date: 31 January 2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · POTASSIUM CHLORIDE
- SeverePotassium Chloride Injection Recalled Nationwide for Mislabeled Strength
FDA (Drugs) · 2025-11-26
- CriticalPotassium Chloride Injection Recalled for Incorrect Strength on Overwrap Label
FDA (Drugs) · 2025-11-26
- SeverePotassium Chloride Injection Recalled: Overwrap Labeling Shows Incorrect Strength
FDA (Drugs) · 2025-03-19
- HighPotassium Chloride Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-02-12
- SeverePotassium Chloride Extended-Release Capsules Recalled Over Failed Dissolution
FDA (Drugs) · 2024-08-07
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27